Related Experiment Video
Updated: Dec 27, 2025

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum
Published on: December 13, 2017
[Cardiac troponins - biomarkers for cardiovascular disease in chronic obstructive pulmonary disease]
Mikael Michelini Truedsson1, Martin Stagmo2, Ingrid Alm Hirsch3
1Capio, Limhamn - vårdcentral Malmö, Sweden Capio, Limhamn - vårdcentral Malmö, Sweden.
Insights
Chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD) frequently coexist. Elevated cardiac troponins in COPD patients, even when stable, indicate myocardial injury and link these conditions.
Area of Science:
- Cardiology
- Pulmonology
- Biomarkers
Background:
- Chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD) share risk factors and pathophysiological pathways.
- COPD is an independent risk factor for CVD, with common comorbidities including ischemic heart disease, heart failure, pulmonary hypertension, and atrial fibrillation.
Purpose of the Study:
- To discuss the intricate association between COPD, CVD, and cardiac troponin elevation.
- To explore the mechanisms behind elevated troponin levels in both stable and exacerbated COPD.
Main Methods:
- Literature review and synthesis of existing research on COPD, CVD, and cardiac troponins.
- Analysis of studies investigating cardiac troponin levels in COPD patients.
Main Results:
- Cardiac troponin elevation is observed in both stable and acutely exacerbated COPD.
- Elevated troponins in COPD signify myocardial injury, highlighting the cardiac implications of this pulmonary condition.
Conclusions:
- The link between COPD, CVD, and cardiac troponins is significant and warrants further investigation.
- Understanding these associations is crucial for comprehensive patient management and risk stratification.
Abstract:
Chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD) are frequently associated and share common risk factors, pathophysiological processes, symptoms and clinical signs. Ischemic heart disease, heart failure, pulmonary hypertension and atrial fibrillation are common comorbidities of COPD. COPD has been described as an independent risk factor for CVD. Cardiac troponin elevation, indicating myocardial injury, is associated with both the stable state of COPD and acute exacerbation of COPD. The mechanisms of elevated troponin levels in these conditions are multiple and not fully understood. The aim of this article is to discuss the association between COPD, CVD and cardiac troponins.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...